AlphaMark Advisors, LLC
- SEC CIK
- 0001348183
- Latest filing
- Jan 21, 2025
SRNE holding history
Sorrento Therapeutics, Inc. in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRNE overviewAll 13F holders of SRNEFull Q4 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −2,135−100.0% | Sold out | Holders |
| Q2 2024 | 2,135 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,135 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,135 | $0 | 0.0% | −1,000−31.9% | Reduced | Holders |
| Q3 2023 | 3,135 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,135 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,135 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,135 | $3.00K | <0.1% | −865−21.6% | Reduced | Holders |
| Q3 2022 | 4,000 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 4,000 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,000 | $9.00K | <0.1% | +2,500+166.7% | Added | Holders |
| Q4 2021 | 1,500 | $7.00K | <0.1% | +1,500 | New | Holders |